By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Eli Lilly

Eli Lilly projects $2 billion in sales for 2024 NTD News (Video)23:06
Is Eli Lilly a better stock to buy and hold over the next 10 years than Novo Nordisk? The Motley Fool06:03
Eli Lilly, Novo Nordisk to benefit as Pfizer’s weight loss drug implodes Invezz08:08
US FDA gives second approval to Eli Lilly's drug for type of blood cancer Reuters18:23
Suicide risk from weight-loss drugs prompts more EU questions BNN Bloomberg10:28
Eli Lilly’s Dan Skovronsky on oral GLP-1, ‘slower ramp’ for Alzheimer’s and deals on ‘underappreciated’ assets ENDPOINTS07:20
Eli Lilly’s CFO explains why the company’s newest weight loss drug Zepbound will cost 20% less… Fortune07:10

Latest News

In the last 4 hours

3 Unstoppable Stocks to Buy Right Now The Motley Fool07:01

Yesterday

Eli Lilly granted planning for Dunderrow expansion Echo Live06:10 9-Dec-23

In the last 7 days

What Eli Lilly’s new obesity drug Zepbound means for GLP-1 weight-loss medication prices Quartz13:19 8-Dec-23

Pharma Giant Eli Lilly's Shareholder Bonanza: Announces Hefty 15% Dividend Hike For Q1 Benzinga12:22 8-Dec-23

Eli Lilly Raises Quarterly Dividend by 15% to $1.30 MarketWatch11:46 8-Dec-23

Lilly Announces 15% Dividend Increase, First-Quarter 2024 Dividend PR Newswire (Press Release)11:32 8-Dec-23

Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market? The Motley Fool05:41 8-Dec-23

Eli Lilly Projects $2 Billion In Sales for 2024 NTD News (Video)23:06 7-Dec-23

Eli Lilly Launches New Obesity Drug Zepbound in U.S. Pharmacies Shore News Network10:46 7-Dec-23

Eli Lilly’s latest $1.4 billion deal might come unglued STAT09:16 7-Dec-23

Should You Buy Eli Lilly Stock Now or Wait for a Dip? The Motley Fool08:38 7-Dec-23

Trial finds Lilly’s Olumiant could treat type 1 diabetes pharmaphorum06:28 7-Dec-23

Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly? The Motley Fool05:56 7-Dec-23

Weight-loss drug Zepbound now available at U.S. pharmacies UPI17:20 6-Dec-23

Eli Lilly says weight loss drug Zepbound is now available WXYZ TV, Detroit16:01 6-Dec-23

LY-3885125 by Eli Lilly and Co for Dyslipidemia: Likelihood of Approval Pharmaceutical Technology13:15 6-Dec-23

New Weight-Loss Drug Zepbound Is Now Available, Company Says U.S. News & World Report13:02 6-Dec-23

Weight loss drug Zepbound is now available, Eli Lilly says CNN18:40 5-Dec-23

Eli Lilly obesity drug hits US pharmacy shelves Reuters - YouTube16:04 5-Dec-23

New weight-loss drug Zepbound now available in US pharmacies TurnTo23.com, California14:25 5-Dec-23

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages CNBC13:06 5-Dec-23

What We’re Reading: Low Rates of COVID-19 Boosters in Nursing Homes; Racial Discrimination in Health Care; New Obesity… American Journal of Managed Care12:54 5-Dec-23

Eli Lilly's weight loss drug Zepbound is now available at US pharmacies Proactive Investors (US)12:46 5-Dec-23

FDA-Approved Zepbound Weight Loss Drug Available In U.S. Pharmacies Forbes11:33 5-Dec-23

Novartis' Pluvicto readout is causing trouble for Eli Lilly’s $1.4B radiotherapy buy FierceBiotech11:22 5-Dec-23

Eli Lilly’s (NYSE:LLY) Obesity Treatment Zepbound Enters the U.S. Obesity Market TipRanks11:11 5-Dec-23

Eli LIlly Obesity Drug Zepbound Available In US Pharmacies European Pharmaceutical Manufacturer10:00 5-Dec-23

Eli Lilly’s New Weight-Loss Drug Now on Sale to Rival Hard-to-Find Wegovy BNN Bloomberg09:12 5-Dec-23

Eli Lilly and Company’s GLP-1 Weight Loss Drug Is Now Available in the US for as Low as $25 Wccftech09:09 5-Dec-23

Eli Lilly Announces Availability Of Zepbound In U.S. Pharmacies - Quick Facts RTT News08:18 5-Dec-23

Eli Lilly's obesity drug now available in U.S. pharmacies Reuters08:13 5-Dec-23

Zepbound™ (tirzepatide) is Now Available in U.S. Pharmacies for Adults Living with Obesity PR Newswire (Press Release)07:39 5-Dec-23

Small Molecule to Agonize Dopamine D1 Receptor for Dementia Associated with Parkinson’s Disease … Pharmaceutical Technology23:32 4-Dec-23

Pro Research: Wall Street takes on Eli Lilly's prospects Investing.com15:34 4-Dec-23

Roche Will Buy Obesity And Diabetes Drugmaker Carmot Therapeutics In $2.7 Billion Deal Forbes14:31 4-Dec-23

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030 CNBC09:46 4-Dec-23

Roche takes on weight-loss drug firms Financial Mail09:17 4-Dec-23

Roche joins obesity drug chase with $2.7B deal for startup Carmot BioPharma Dive09:03 4-Dec-23

Lilly Wins Second Accelerated Approval for Reversible BTK Inhibitor BioSpace08:24 4-Dec-23

FDA Grants Second Conditional Approval For Eli Lilly's Rare Blood Cancer Drug Benzinga08:23 4-Dec-23

Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs Benzinga08:23 4-Dec-23

VICI, LLY, ET Stocks: 3 Analyst Favorites with “Strong Buy” Technical Indicators TipRanks08:13 4-Dec-23

Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It Hopes to Compete with Eli Lilly, Novo Nordisk. Barron's Online07:53 4-Dec-23

Roche weighs in on obesity drug market with $2.7bn Carmot buy BioProcess Insider07:46 4-Dec-23

Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas PMLiVE07:41 4-Dec-23

Eli Lilly extends tender offer to buy Point Biopharma to Dec. 15 Reuters07:27 4-Dec-23

Career advice from the CFOs of Dell, Eli Lilly, and Marriott—3 women who have each spent… Fortune07:16 4-Dec-23

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023 PR Newswire (Press Release)06:50 4-Dec-23

Eli Lilly’s Jaypirca approved in US for leukaemia and lymphoma treatment Pharmafile06:09 4-Dec-23

Eli Lilly Receive Second FDA Approval For Blood Cancer Drug European Pharmaceutical Manufacturer04:13 4-Dec-23

Roche enters obesity drug market with Carmot deal RTE03:29 4-Dec-23

Eli Lilly receives approval for Jaypirca to treat CLL/SLL in adults Pharmaceutical Technology03:19 4-Dec-23

Is Eli Lilly Stock A Buy After Mounjaro Beats Out Ozempic In A Head-To-Head Analysis? Investors Business Daily19:15 3-Dec-23

In the last month

Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk? The Motley Fool06:03 2-Dec-23

Atopic Dermatitis Market to grow significantly by 2032 | Sanofi, Regeneron Pharmaceuticals,… Industry Today04:03 2-Dec-23

FDA gives second approval to Eli Lilly's drug for type of blood cancer The Economic Times21:50 1-Dec-23

Eli Lilly's cancer drug gets second approval from US FDA Livemint.com21:03 1-Dec-23

Regulators are looking into whether weight-loss drugs like Ozempic raise the risk of suicidal… Fortune19:48 1-Dec-23

US FDA gives second approval to Eli Lilly's drug for type of blood cancer Reuters18:23 1-Dec-23

Eli Lilly's Leukemia Treatment Jaypirca Gets FDA Approval MarketWatch17:43 1-Dec-23

Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly CNBC13:31 1-Dec-23

Why investors should stick with Eli Lilly CNBC11:38 1-Dec-23

Suicide Risk From Weight-Loss Drugs Prompts More EU Questions BNN Bloomberg10:28 1-Dec-23

1 Underrated Reason to Buy Eli Lilly Stock The Motley Fool09:52 1-Dec-23

Eli Lilly, Novo Nordisk to benefit as Pfizer’s weight loss drug implodes Invezz08:08 1-Dec-23

Bubble Warning: Unrealistic Growth Priced In And Multiple Risk Factors For Eli Lilly Seeking Alpha11:01 30-Nov-23

Thinking about trading options or stock in Eli Lilly And Co, Apple, Uber Technologies, Pure… PR Newswire (Press Release)09:32 30-Nov-23

Eli Lilly and PRISM BioLab enter drug discovery collaboration worth over $660m PMLiVE07:40 30-Nov-23

Arecor continues collaboration with Lilly UK BioIndustry Association06:50 30-Nov-23

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less… Yahoo! US06:44 30-Nov-23

L.A. Care Health Plan, Eli Lilly and Company, and Angel Care Inc. - Sponsors of the 2023 Golden … PRWeb (Press Release)06:06 30-Nov-23

Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy? The Motley Fool05:32 30-Nov-23

Japanese firm PRISM BioLab inks $660 M drug discovery pact with Eli Lilly BioSpectrum Asia23:38 29-Nov-23

Eli Lilly Partners With Prism BioLab In Deal Worth $660M Law36020:41 29-Nov-23

Eli Lilly advances small molecule drug portfolio with Prism Biolab partnership Pharmaceutical Technology11:55 29-Nov-23

Verve Stock Takes a Hit on $148M Offering to Public, Lilly BioSpace11:33 29-Nov-23

Alexandria (ARE), Eli Lilly to Expand Gateway Labs to San Diego Zacks09:39 29-Nov-23

Trading updates: Arecor inks Eli Lilly deal; Rbg appoints McNair CFO London South East09:29 29-Nov-23

Lilly Puts Potential $660M on the Line for Protein-Protein Interaction Blockers BioSpace09:11 29-Nov-23

Verve raises $148M via public stock offering, private placement with Eli Lilly ENDPOINTS07:20 29-Nov-23

Eli Lilly’s Dan Skovronsky on oral GLP-1, ‘slower ramp’ for Alzheimer’s and deals on ‘underappreciated’ assets ENDPOINTS07:20 29-Nov-23

Eli Lilly’s CFO explains why the company’s newest weight loss drug Zepbound will cost 20% less… Fortune07:10 29-Nov-23

Can a Big Pharma Ever Be Worth $1 Trillion? The Wall Street Journal07:01 29-Nov-23

Pediatric Drugs Market: The Growth Cycle Continues| Bayer, Eli Lilly, Novo Nordisk Industry Today04:28 29-Nov-23

Arecor extends its relationship with Lilly as it inks another technology deal Proactive Investors (UK)02:31 29-Nov-23

What to Know About Zepbound The Cut15:24 28-Nov-23

Eli Lilly (NYSE:LLY) Pops Up After Beating Novo Nordisk (NYSE:NVO) In Weight Loss TipRanks12:11 28-Nov-23

Radiopharmaceuticals reach record high with $408m in venture financing for 2023 Pharmaceutical Technology08:35 28-Nov-23

Lilly To Open New Gateway Labs Location In Partnership With Alexandria Real Estate Equities RTT News08:32 28-Nov-23

Pharma's Q3 growth rankings: GLP-1 drugs from Eli Lilly, Novo Nordisk were once again the big… FiercePharma03:02 28-Nov-23

Teva, Eli Lilly Call Off Infringement Suit Over Migraine Drug Law36019:29 27-Nov-23

Mounjaro Outperforms Ozempic in Weight Loss Effectiveness, Study Finds Business Times17:34 27-Nov-23

Biden Plans to Boost Drug Production Using Cold-War Era Law TipRanks15:30 27-Nov-23

Local Virginia governments add to insulin lawsuits against Eli Lilly, Novo Nordisk, Sanofi, others ENDPOINTS15:02 27-Nov-23

Mounjaro outperforms Ozempic for weight loss in adults, study says Proactive Investors (US)13:42 27-Nov-23

GLP-1 Drug War: Obese Patients Are Typically Twice as Likely To Lose 15% Or More of Their Body… Wccftech12:25 27-Nov-23

Pro Research: Wall Street Eyes Eli Lilly's Bright Prospects Investing.com11:08 27-Nov-23

Eli Lilly’s Mounjaro three times more effective than Ozempic for weight loss, real-world study finds MarketWatch10:40 27-Nov-23

How To Make a Weight-Loss Drug Go Viral BNN Bloomberg05:35 27-Nov-23

Synthetic Hormones Market Analysis Report 2023-2033, Featuring Profiles of Eli Lilly, Pfizer, Ferring, Merck, Novo… GlobeNewswire (Press Release)04:31 27-Nov-23

The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce Zacks04:10 27-Nov-23

FDA approves new version of Eli Lilly’s diabetes drug for weight loss Miami Herald09:02 26-Nov-23

Could Ozempic Harm These 3 Medical Device Stocks? The Motley Fool07:04 25-Nov-23

Teva drops migraine-drug patent case against Eli Lilly Reuters15:03 24-Nov-23

Nissan, Eli Lilly rise; Nvidia, Alphabet fall, 11/24/2023 Mail Online13:26 24-Nov-23

Novo Nordisk: Eli Lilly's Zepbound Approval Is Not A Threat To Valuation Seeking Alpha11:13 24-Nov-23

Investigators believe New York man and his wife were killed in Bentley that exploded at US-Canada bridge, sources say.… San Gabriel Valley Tribune, California17:03 23-Nov-23

Eli Lilly hosts 2023 Pharma Leaders Conference Chemical & Engineering News10:44 23-Nov-23

Eli Lilly on track to potentially outvalue Tesla by 2027 Investing.com09:48 23-Nov-23

Will Eli Lilly Be Worth More Than Tesla by 2027? The Motley Fool09:16 23-Nov-23

Eli Lilly (LLY) Stock Outperforms Industry YTD: Here's Why Zacks07:33 23-Nov-23

US International Trade Commission takes on Eli Lilly's tirzepatide case ENDPOINTS13:17 22-Nov-23

Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant The Motley Fool08:19 22-Nov-23

Cytotoxic Drug Market Is Thriving Worldwide with Roche Holding, Eli Lilly, Celgene, Sanofi Industry Today07:12 22-Nov-23

Eli Lilly Gets ITC To Launch Probe Into Diabetes Drug Imports Law36015:49 21-Nov-23

view more headlines

10 Dec 07:01

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.